One Cancer. One Cure.

One Cure was founded on the principle that cancer affects all creatures and that treatment breakthroughs come through collaborations between scientists and doctors who are working with pets and people. For more than three decades, the Flint Animal Cancer Center has been the world’s leader in comparative oncology research. By establishing partnerships with the National Cancer Institute, academic institutions, and foundations we are committed to growing the field and conquering cancer in all species. 

Gifts to One Cure support our Clinical Trials program which is the largest in veterinary medicine. Each year, the One Cure team manages approximately 30 clinical trials to study more effective therapies for a variety of cancer types including, osteosarcoma, lymphoma, soft tissue sarcoma, and brain tumors. 

The Promise of Comparative Oncology

Comparative oncology is the study of naturally occurring cancers in more than one species. In particular, studies of companion dogs provide valuable information in our quest for understanding. Now more than ever, thanks to loving owners who seek specialized veterinary care when their pet is diagnosed with cancer, we have incredible opportunities to learn. Through companion animal clinical trials, we’re finding better and less costly treatments, improved diagnostic tools, and even preventative interventions, which can benefit all cancer patients. 

The Answer to Cancer May Be Walking Right Beside Us

WHY DOGS?

Studying canine cancer helps us learn more about human cancer.

  • Cancers in dogs develop naturally, just like in people

  • Dogs live in the same environment, breathe the same air, and drink the same water

  • People and dogs have similar immune systems 

  • Dogs share 85% of our genetic make-up


Cancers in dogs and people share many features.

  • Appearance under a microscope

  • Tumor growth and spread

  • Response to conventional treatment (chemotherapy, surgery, and radiation) and novel therapies
     

Canine trials decrease the time & cost of drug development. 

  • Clinical trials in dogs offer a more flexible design 

  • Duration of a canine study is 1-3 years vs. 5-10 years in people
     



 


One Cure Stories of Hope

One Cure provides critical funding for the clinical trials research program at the Flint Animal Cancer Center. The goal of our clinical trials program is to find better treatment options for cancer patients, both pets and humans, that improve outcomes, reduce side effects, and hopefully, one day, find a cure. With owner consent, our canine and feline patients are pioneers in cancer research, helping us move cutting-edge treatments off the laboratory bench and into clinical practice; providing hope for today’s patients and the next generation of animal and human cancer patients.